002562 Brother Enterprises Holding
- 2.89
- 0.000.00%
Brother Enterprises Holding News
Brother Enterprises Holding's Q1 2024 financial report analysis: net income declined, improved cash flow situation.
Brother Enterprises Holding (Stock Code: 002562) recently released its Q1 2024 financial report. As a focus of market attention, the report details the company's financial condition and business performance during the reporting period. Here is an in-depth interpretation of Brother Enterprises Holding's Q1 report. First, we focus on the company's asset and liability data. The report shows that the total assets at the end of this reporting period were 5.843 billion yuan, slightly down from the end of the previous year, a decrease of 0.75%. This is mainly due to the structural adjustment of the company's liabilities and equity. In terms of liabilities, although the total amount of liabilities at the end of the period was 2.817 billion yuan, a decrease from the beginning of the period, but...
Pharmaceutical stocks generally strengthened. Taiji Group rose more than 5%, while Brother Technology, Donga Ejiao, China Resources 39, and Dongcheng Pharmaceutical had the highest gains.
Pharmaceutical stocks generally strengthened. Taiji Group rose more than 5%, while Brother Technology, Donga Ejiao, China Resources 39, and Dongcheng Pharmaceutical had the highest gains.
Brother Enterprises' Unit Gets Nod to Market Iopamidol in Europe
Brother Enterprises Holding's (SHE:002562) unit, Jiangxi Brother Pharmaceutical, obtained the suitability certificate suitability from the European Directorate for the Quality of Medicines & HealthCar
Brother Technology (002562.SZ): Does not involve chemical synthesis of polyether ether ketone
Gelonghui, May 20 | Brother Technology (002562.SZ) said on the investor interactive platform that the company is not involved in the chemical synthesis of polyether ether ketone. Polyether ether ketone is a key application area for hydroquinone, and the company is still in the promotion stage.
Express News | Brother Technology: Wholly-owned subsidiary obtains CEP certificate for APIs
Express News | Brother Technology: Terminate construction project with an annual output of 30,000 tons of natural flavors
Brother Technology (002562.SZ): Net loss of 25.2 million yuan in the first quarter turned into a year-on-year loss
Gelonghui, April 29 | Brother Technology (002562.SZ) released its first quarter report. Operating revenue was 800 million yuan, up 21.1% year on year, net loss of 25.2 million yuan, turning loss year on year. After deducting non-net loss of 257.975 million yuan, basic earnings per share -0.0237 yuan.
Brother Technology (002562.SZ) issued a forecast loss. The net loss for the first quarter is expected to be 20 million yuan to 26 million yuan, changing from profit to loss over the previous year
Brother Technology (002562.SZ) released a performance forecast for the first quarter of 2024, which is expected to be owned by a listed company...
The vitamin concept fluctuated, and many stocks such as Brother Technology rose and stopped
The vitamin concept has fluctuated and strengthened. As of press release, many individual stocks such as Guanfu shares, Zhenhua shares, and Brother Technology have risen or stopped. Zhejiang Pharmaceuticals and Huayuan Biotech have risen more than 8%, and Xinhe Cheng, Covex shares, and Northeast Pharmaceuticals have all surged.
Brother Technology (002562.SZ): Hydroquinone is mainly used as a polymerization inhibitor in the petrochemical field
Gelonghui, April 10 | Brother Technology (002562.SZ) said on the investor interactive platform that the hydroquinone produced by the company is mainly used in the fields of polymerization inhibitors in the petrochemical industry, anti-aging agents in the rubber industry, and food antioxidants.
Brother Technology (002562.SZ): Hydroquinone products are now fully sold to mainstream domestic acrylic acid manufacturers
Gelonghui, April 10 | Brother Technology (002562.SZ) said on the investor interactive platform that the company's hydroquinone products are now fully sold to mainstream domestic acrylic acid producers.
Express News | Brother Technology: The subsidiary's application for the marketing of the chemical raw material iohexol was approved.
Express News | Brother Technology: The subsidiary received a notice of approval for the marketing application of iohexol as an API
Brother Technology (002562.SZ): Currently, some products in the company's pharmaceutical sector involve cooperation with CRO companies
Gelonghui, March 12: An investor asked Brother Technology (002562.SZ) on the investor interactive platform, “Does the company involve the CXO concept?” The company replied that currently some products in the company's pharmaceutical sector involve cooperation with CRO companies, and in the future, the pharmaceutical sector will gradually develop the CMO/CDMO business for APIs and formulations.
Brother Technology (002562.SZ): Some of the company's products have entered the Indian market
On March 8, GLONGHUI | Brother Technology (002562.SZ) said on the investor interactive platform that some of the company's products have entered the Indian market and will continue to increase the promotion and layout of the global market in the future.
Brother Technology (002562.SZ): Wholly-owned subsidiary once again approved as a high-tech enterprise
Gelonghui, Feb. 2: Brother Technology (002562.SZ) announced that its wholly-owned subsidiary Jiangxi Brother Pharmaceutical Co., Ltd. recently received a “High-tech Enterprise Certificate” jointly issued by the Jiangxi Provincial Department of Science and Technology, the Jiangxi Provincial Department of Finance, and the Jiangxi Provincial Taxation Bureau of the State Administration of Taxation. The certificate number is GR202336001070. The date of issue is November 22, 2023, and is valid for three years. This is a re-certification carried out after the expiration of Brother Pharmaceuticals's original high-tech enterprise certificate.
Express News | Brother Technology: Terminate the investment agreement for the construction of an international pharmaceutical industry base
Brother Technology (002562.SZ): Expected net loss of 150 million yuan to 190 million yuan in 2023
On January 30, GLONGHUI | Brother Technology (002562.SZ) announced that it expects a net loss of 150,000,000 yuan to 190.01 million yuan in 2023, after deducting non-net loss of 210,000 yuan to 250,000 yuan. During the reporting period, due to market changes and industry cyclicality, sales prices of the company's vitamins, flavors, chromium salts and other related products declined, and product gross margin declined, leading to a loss in the company's 2023 performance. During the reporting period, the company's non-recurring revenue was mainly due to receiving dividends and interest from Jiaxing Zhonghua Chemical Co., Ltd. 4,13
Brother Technology (002562.SZ): Subsidiary obtains CEP certificate for APIs
Gelonghui, January 21丨Brother Technology (002562.SZ) announced that Jiangxi Brother Pharmaceutical Co., Ltd. (“Brother Pharmaceuticals”), a wholly-owned subsidiary of the company, recently received the European Pharmacopeia applicability certificate (“CEP certificate”) issued by the European Drug Quality Administration. Iohexol is widely used in angiography, subarachnography, coronary angiography, spinal cord and hip joints, urinary system imaging, CT enhanced scanning, etc., and has the advantages of low osmotic pressure, low neurotoxicity, low contrast density, and good tolerability. Currently, the global market demand for iohexol APIs is expected to be around 5,00
Brother Technology (002562.SZ): The company's chromium salt products have cooperated with some pigment customers
Gelonghui, January 17丨Brother Technology (002562.SZ) said on the investor interactive platform that the company's chromium salt products have cooperated with some pigment customers, and the company will further actively explore the market in the future
Analysis
Price Target
No Data
